Washington, DC // ZERO is launching the Decode Your Prostate Cancer program in partnership with Perthera, the leading Therapeutics Intelligence Company™, to give men battling advanced prostate cancer the ability to create individualized treatment plans. Every patient’s prostate cancer is as unique as his genes. As we continue to fight this terrible disease, personalized medicine is more important than ever.
Perthera and ZERO Announce the Decode Your Prostate Cancer Program
AI-enabled precision, speed and scale
Precision oncology and speed to decision, for everyone, at every point of care.How We Help